Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

“Emerging Innovators Transforming Global Markets: IPA, CRDL, KXIN, GNS, PRSO in Sectors”

“Emerging Innovators Transforming Global Markets: IPA, CRDL, KXIN, GNS, PRSO in Sectors”

The latest breakthroughs from leading innovators across healthcare, technology, and energy sectors spotlight with each of the companies below pushing boundaries in their fields. From pioneering antibody therapies for cancer and expanding biotech treatment options to advancing electric vehicle production, adopting blockchain-focused strategies, and driving demand in mmWave wireless technology, these companies are reshaping the landscape of their industries.

$20B Market Milestone: IPA Advances Antibody Development for Next-Gen Cancer Therapies

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) is making waves in AI-driven medical innovation with a significant milestone in cancer research. Their TATX-112 program targets TrkB protein expression in cancer cells, with promising candidates for further development. This positions IPA strategically in the projected $20.7 billion cancer-fighting antibody market by 2028.

Cardiol Therapeutics Added to Emerging Biotech Index Gaining Momentum with Orphan Drug Designation

Cardiol Therapeutics Inc. (NASDAQ: CRDL) recently received FDA Orphan Drug Designation for CardiolRx™ in treating pericarditis, with a robust MAVERIC Program underway. The upcoming MAVERIC-2 trial, launching in Q4 2024, aims to assess CardiolRx™’s impact on patients with recurrent pericarditis, preparing for pivotal advancements in treatment options.

Kaixin Holdings Shifts Gears to Dominate China’s Electric Vehicle Market

Kaixin Holdings (NASDAQ: KXIN) leverages its advanced R&D, production capacity, and sustainable vision to make strides in China’s electric vehicle industry. Kaixin is set to establish a strong international presence, aligning with China’s environmental goals for peak carbon emissions and neutrality. The company recently regained NASDAQ compliance, strengthening its growth trajectory.

Genius Group Leads with Bitcoin-First Treasury Strategy

Genius Group Limited (NYSE American: GNS) adopted Bitcoin as its primary treasury reserve asset, aligning its strategy with a Blockchain-focused Board. This "Bitcoin-first" policy solidifies Genius Group’s commitment to Blockchain and Web3 innovation as it enhances its AI-powered education platform.

Peraso’s Technology Fuels Global Demand

Peraso Inc. (NASDAQ: PRSO) reported $3.84M in Q3, driven by increasing design wins in fixed wireless access, military, and transportation sectors. Recent orders from wireless Internet service providers in South Africa and Kenya highlight the global adoption of Peraso’s DUNE platform for dense urban environments, solidifying its position in mmWave technology.

With strategic positioning in high-growth markets and a commitment to cutting-edge innovation, these companies are poised to drive impactful changes, reflecting significant advancements across healthcare, technology, and sustainability sectors.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.